Standard BioTools Inc. (LAB)
NASDAQ: LAB · IEX Real-Time Price · USD
2.440
+0.080 (3.39%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Standard BioTools Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 51.7 | 81.31 | 28.45 | 68.52 | 21.66 | 95.4 | 58.06 | 35.05 | 29.12 | 33.71 | Upgrade
|
| Short-Term Investments | 63.19 | 84.48 | 0 | 0 | 36.98 | 0 | 5.08 | 24.39 | 65.86 | 81.59 | Upgrade
|
| Cash & Cash Equivalents | 114.9 | 165.78 | 28.45 | 68.52 | 58.64 | 95.4 | 63.14 | 59.43 | 94.97 | 115.3 | Upgrade
|
| Cash Growth | -30.70% | 482.70% | -58.48% | 16.85% | -38.53% | 51.10% | 6.24% | -37.42% | -17.63% | 36.70% | Upgrade
|
| Receivables | 19.66 | 17.28 | 18.32 | 25.42 | 18.98 | 16.65 | 15.05 | 14.61 | 25.46 | 22.38 | Upgrade
|
| Inventory | 20.53 | 21.47 | 20.83 | 19.69 | 13.88 | 13 | 15.09 | 20.11 | 17.92 | 15.99 | Upgrade
|
| Other Current Assets | 3.13 | 4.28 | 4.47 | 4.03 | 4.59 | 2.05 | 1.53 | 2.52 | 5.74 | 2.22 | Upgrade
|
| Total Current Assets | 158.22 | 208.82 | 72.07 | 117.66 | 96.1 | 127.11 | 94.8 | 96.67 | 144.1 | 155.9 | Upgrade
|
| Property, Plant & Equipment | 54.85 | 59.54 | 65.15 | 55.65 | 12.92 | 8.83 | 12.3 | 16.53 | 15.26 | 13.89 | Upgrade
|
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.49 | 27.5 | Upgrade
|
| Goodwill and Intangibles | 107.72 | 118.85 | 134.31 | 146.77 | 150.31 | 161.51 | 172.71 | 183.91 | 195.11 | 206.31 | Upgrade
|
| Other Long-Term Assets | 2.29 | 3.11 | 3.69 | 4.68 | 5.49 | 6.21 | 7.54 | 9.29 | 9.1 | 3.97 | Upgrade
|
| Total Long-Term Assets | 164.85 | 181.5 | 203.15 | 207.09 | 168.72 | 176.54 | 192.55 | 209.72 | 225.96 | 251.66 | Upgrade
|
| Total Assets | 323.07 | 390.31 | 275.21 | 324.76 | 264.81 | 303.65 | 287.35 | 306.4 | 370.05 | 407.56 | Upgrade
|
| Accounts Payable | 9.24 | 7.91 | 10.6 | 9.22 | 5.15 | 4.03 | 4.21 | 3.97 | 6.09 | 5.92 | Upgrade
|
| Deferred Revenue | 29.49 | 32.61 | 39.56 | 45.41 | 19.97 | 17.79 | 15.2 | 13.48 | 13.82 | 11.29 | Upgrade
|
| Current Debt | 63.85 | 5.77 | 9.89 | 2.97 | 1.83 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Current Liabilities | 6.74 | -2.85 | -10.49 | -3.36 | 5.87 | 15.76 | 14.07 | 12.06 | 10.17 | 12.18 | Upgrade
|
| Total Current Liabilities | 109.33 | 43.44 | 49.57 | 54.25 | 32.82 | 37.58 | 33.47 | 29.5 | 30.08 | 29.39 | Upgrade
|
| Long-Term Debt | 34.36 | 96.89 | 101.76 | 92.4 | 58.14 | 172.06 | 195.24 | 194.95 | 194.67 | 195.46 | Upgrade
|
| Other Long-Term Liabilities | 16.18 | 20.19 | 29.29 | 39.06 | 20.24 | 21.89 | 27.7 | 28.71 | 30.4 | 32.3 | Upgrade
|
| Total Long-Term Liabilities | 50.54 | 117.08 | 131.05 | 131.46 | 78.38 | 193.95 | 222.94 | 223.66 | 225.07 | 227.76 | Upgrade
|
| Total Liabilities | 159.87 | 160.52 | 180.62 | 185.71 | 111.2 | 231.53 | 256.42 | 253.16 | 255.15 | 257.14 | Upgrade
|
| Total Debt | 98.21 | 102.66 | 111.65 | 95.38 | 59.98 | 172.06 | 195.24 | 194.95 | 194.67 | 195.46 | Upgrade
|
| Debt Growth | -4.33% | -8.05% | 17.06% | 59.02% | -65.14% | -11.87% | 0.15% | 0.14% | -0.40% | - | Upgrade
|
| Retained Earnings | -1,000.75 | -926.1 | -736 | -676.76 | -623.64 | -558.85 | -500.2 | -439.48 | -363.49 | -310.18 | Upgrade
|
| Comprehensive Income | -2.22 | -1.9 | -0.91 | 0.11 | -0.58 | -0.69 | -0.57 | -0.76 | -1.14 | -0.79 | Upgrade
|
| Shareholders' Equity | -148.05 | -81.47 | 94.6 | 139.05 | 153.61 | 72.12 | 30.94 | 53.23 | 114.9 | 150.42 | Upgrade
|
| Net Cash / Debt | 16.69 | 63.13 | -83.2 | -26.86 | -1.34 | -76.66 | -132.1 | -135.52 | -99.7 | -80.15 | Upgrade
|
| Net Cash / Debt Growth | -73.57% | - | - | - | - | - | - | - | - | - | Upgrade
|
| Net Cash Per Share | 0.21 | 0.81 | -1.10 | -0.37 | -0.02 | -1.93 | -4.01 | -4.67 | -3.47 | -2.89 | Upgrade
|
| Working Capital | 48.89 | 165.37 | 22.5 | 63.41 | 63.28 | 89.52 | 61.33 | 67.17 | 114.01 | 126.51 | Upgrade
|
| Book Value Per Share | -1.87 | -1.04 | 1.25 | 1.93 | 2.30 | 1.82 | 0.94 | 1.83 | 4.00 | 5.42 | Upgrade
|